oral glp-1 agonist approved List of and pending medications Novel oral GLP-1 receptor agonist

Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats

Future efforts should address affordability and accessibility through health economic analyses and policy-driven approaches

Weight loss results vary by drug, with Rybelsus producing more modest losses (~6% in a year) and Foundayo and Wegovy producing results on par with injections (up to ~11%--14% in a year, respectively)

Geldmacher DS, Fritsch T, McClendon MJ, Landreth G

In the human body, the PLG polymers slowly degrade through the non-catalyzed hydrolysis of the ester linkages into lactic acid and glycolic acid, which are finally eliminated as carbon dioxide and water